v3.25.2
BUSINESS SEGMENT INFORMATION (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information [Line Items]        
Revenues $ 3,527.3 $ 3,220.9 $ 6,872.4 $ 6,397.5
Operating income 394.5 294.8 720.5 616.1
Amortization of Intangible Assets (68.3) (62.2) (137.9) (122.3)
Net Restructuring Charges (4.1) (11.6) (10.5) (16.6)
Goodwill and Intangible Asset Impairment     0.0 (2.5)
Interest expense (57.1) (47.6) (113.1) (94.5)
Investment income 1.7 1.3 8.2 4.2
Equity method loss, net (1.7) (0.3) (2.0) (0.2)
Other, net (32.7) 19.5 (33.7) 39.5
Earnings before income taxes 304.7 267.7 579.9 565.1
Asset Impairment Charges 0.0 0.0 0.0 (2.5)
Operating Segments        
Segment Reporting Information [Line Items]        
Operating income 606.1 548.9 1,140.5 1,066.7
Intersegment Eliminations        
Segment Reporting Information [Line Items]        
Revenues 6.3 11.0 12.1 25.0
Corporate Segment [Member]        
Segment Reporting Information [Line Items]        
Operating income (139.2) (180.3) (271.6) (309.2)
Diagnostics        
Segment Reporting Information [Line Items]        
Labor and Related Expense 1,155.1 1,072.6 2,278.7 2,128.3
Supplies Expense 591.3 544.3 1,177.9 1,104.7
Other Cost and Expense, Operating 454.2 403.4 884.4 787.4
Diagnostics | Operating Segments        
Segment Reporting Information [Line Items]        
Revenues 2,748.8 2,524.9 5,378.4 5,004.6
Depreciation 65.4 63.1 127.1 124.8
Operating income 482.8 441.5 910.3 859.4
Biopharma Laboratory Services        
Segment Reporting Information [Line Items]        
Labor and Related Expense 302.3 285.7 592.0 576.1
Supplies Expense 130.8 106.7 241.9 210.2
Freight 98.2 89.7 193.2 178.1
Other Cost and Expense, Operating 101.2 87.2 191.2 184.7
Biopharma Laboratory Services | Operating Segments        
Segment Reporting Information [Line Items]        
Revenues 784.8 707.0 1,506.1 1,417.9
Depreciation 29.0 30.3 57.6 61.5
Operating income $ 123.3 $ 107.4 $ 230.2 $ 207.3